Santa Cruz Biotechnology offers a broad range of Gram Negative Endotoxin Marker monoclonal antibodies for the detection and analysis of endotoxins derived from Gram-negative bacteria. Gram Negative Endotoxin Marker Antibodies are extensively used in western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Gram-negative endotoxins, primarily lipopolysaccharides (LPS), play a crucial role in the immune response and can trigger severe inflammatory reactions. Their presence is significant in studies related to sepsis, bacterial infections, and immune system responses. Understanding the function and impact of Gram-negative endotoxins is essential for developing therapeutic strategies and improving clinical outcomes. Lipopolysaccharides are key components of the outer membrane of Gram-negative bacteria and serve as important biomarkers in infection research. Advanced research techniques utilizing monoclonal antibodies have enhanced our understanding of bacterial pathogenesis and host immune responses. Gram Negative Endotoxin Marker monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance scientific knowledge in bacterial infection and immune response studies.